A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients (notice n° 603571)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02199cam a2200253 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121154855.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Arne, Vrysen |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2021.<br/> |
500 ## - GENERAL NOTE | |
General note | 40 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | BackgroundChronic immunosuppression is a risk factor for cutaneous melanoma, as indicated by the increased incidence among solid organ transplant recipients (OTRs). The outcome of post-transplant melanomas has not frequently been investigated. ObjectivesThe aim of this narrative review was to investigate overall survival (OS) and melanoma-specific mortality (MSM) of primary cutaneous melanomas (CM) among OTRs compared to the outcome of cutaneous melanomas arising in immunocompetent patients. Materials & MethodsA systematic literature search was conducted in PubMed to identify studies reporting on primary CM among OTRs and their outcome. The search was restricted to the English language and included investigations through to April 1st, 2019. ResultsOf the seven articles included, all except one reported a lower OS for primary CM among OTRs compared to immunocompetent patients. In these six investigations, MSM was increased, but not relative to Clark level, Breslow thickness or American Joint Committee on Cancer (AJCC) stage. ConclusionA lower OS can be expected among OTRs with primary CM. There is still much heterogeneity in MSM adjusted for Breslow thickness, AJCC staging and Clark level, with no conclusive answers. Prospective studies are needed to clarify MSM for this specific patient group. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | solid organ transplantation |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | melanoma |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | melanoma-specific survival |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | overall survival |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | melanoma specific mortality |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | organ transplant recipients |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Canan, Güvenç |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marjan, Garmyn |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | European Journal of Dermatology | 31 | 3 | 2021-05-01 | p. 364-371 | 1167-1122 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-european-journal-of-dermatology-2021-3-page-364?lang=en&redirect-ssocas=7080">https://shs.cairn.info/revue-european-journal-of-dermatology-2021-3-page-364?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux